AU1481399A - Topical ophthalmic preparations containing immunosuppressive agents - Google Patents

Topical ophthalmic preparations containing immunosuppressive agents

Info

Publication number
AU1481399A
AU1481399A AU14813/99A AU1481399A AU1481399A AU 1481399 A AU1481399 A AU 1481399A AU 14813/99 A AU14813/99 A AU 14813/99A AU 1481399 A AU1481399 A AU 1481399A AU 1481399 A AU1481399 A AU 1481399A
Authority
AU
Australia
Prior art keywords
preparations containing
immunosuppressive agents
topical ophthalmic
ophthalmic preparations
containing immunosuppressive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14813/99A
Inventor
Alexandr Jegorov
Vladimir Matha
Josef Stuchlik
Milan Stuchlik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ivax Pharmaceuticals sro
Original Assignee
Galena AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galena AS filed Critical Galena AS
Publication of AU1481399A publication Critical patent/AU1481399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU14813/99A 1997-12-30 1998-12-17 Topical ophthalmic preparations containing immunosuppressive agents Abandoned AU1481399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CZ19974237A CZ287497B6 (en) 1997-12-30 1997-12-30 Topic eye preparations containing immunosuppressive substances
CZ4237-97 1997-12-30
PCT/CZ1998/000054 WO1999034830A1 (en) 1997-12-30 1998-12-17 Topical ophthalmic preparations containing immunosuppressive agents

Publications (1)

Publication Number Publication Date
AU1481399A true AU1481399A (en) 1999-07-26

Family

ID=5467853

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14813/99A Abandoned AU1481399A (en) 1997-12-30 1998-12-17 Topical ophthalmic preparations containing immunosuppressive agents

Country Status (12)

Country Link
EP (1) EP1058560A1 (en)
JP (1) JP2002500200A (en)
AU (1) AU1481399A (en)
BG (1) BG104558A (en)
CA (1) CA2317010A1 (en)
CZ (1) CZ287497B6 (en)
HR (1) HRP20000258A2 (en)
HU (1) HUP0004173A2 (en)
NO (1) NO20003344L (en)
PL (1) PL341604A1 (en)
SK (1) SK284246B6 (en)
WO (1) WO1999034830A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002542150A (en) * 1998-12-24 2002-12-10 株式会社アールテック・ウエノ Agent for treatment of photoreceptor cell dysfunction
US6864232B1 (en) 1998-12-24 2005-03-08 Sucampo Ag Agent for treating visual cell function disorder
AR035293A1 (en) * 2001-08-23 2004-05-05 Novartis Ag OPHTHALMIC COMPOSITION.
ES2428354T3 (en) * 2002-09-18 2013-11-07 Trustees Of The University Of Pennsylvania Rapamycin for use in the inhibition or prevention of choroidal neovascularization
US7354574B2 (en) 2002-11-07 2008-04-08 Advanced Ocular Systems Limited Treatment of ocular disease
US7083802B2 (en) * 2003-07-31 2006-08-01 Advanced Ocular Systems Limited Treatment of ocular disease
US7083803B2 (en) 2003-09-19 2006-08-01 Advanced Ocular Systems Limited Ocular solutions
US7087237B2 (en) 2003-09-19 2006-08-08 Advanced Ocular Systems Limited Ocular solutions
KR20070104931A (en) 2005-02-09 2007-10-29 마커사이트, 인코포레이티드 Formulations for ocular treatment
WO2007011880A2 (en) 2005-07-18 2007-01-25 Minu, L.L.C. Enhanced ocular neuroprotection/neurostimulation
CA2635797C (en) 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
DK2001466T3 (en) 2006-03-23 2016-02-29 Santen Pharmaceutical Co Ltd LOW-DOSAGE RAPAMYCINE FOR TREATMENT OF VASCULAR PERMEABILITY-RELATED DISEASES
WO2014117035A1 (en) 2013-01-24 2014-07-31 Transderm, Inc. COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
US20160074321A1 (en) * 2013-03-27 2016-03-17 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
US11622929B2 (en) 2016-03-08 2023-04-11 Living Proof, Inc. Long lasting cosmetic compositions
CA3049402A1 (en) 2017-01-06 2018-07-12 Palvella Therapeutics Llc Anhydrous compositions of mtor inhibitors and methods of use
WO2019055445A2 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Color protectant compositions
CN111133023B (en) 2017-09-13 2022-10-18 生活实验公司 Long-lasting cosmetic composition
EP3817743A4 (en) 2018-07-02 2022-07-06 Palvella Therapeutics, Inc. Anhydrous compositions of mtor inhibitors and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5051260A (en) * 1987-07-16 1991-09-24 The Regents Of The University Of California Method and composition for enhancing the cutaneous penetration of pharmacologically active agents
US5045317A (en) * 1987-07-16 1991-09-03 The Regents Of The University Of California Enhancing the cutaneous penetration of pharmacologically active agents

Also Published As

Publication number Publication date
WO1999034830A1 (en) 1999-07-15
HUP0004173A2 (en) 2001-08-28
EP1058560A1 (en) 2000-12-13
SK171798A3 (en) 1999-10-08
CZ423797A3 (en) 1999-07-14
HRP20000258A2 (en) 2001-04-30
BG104558A (en) 2001-02-28
CA2317010A1 (en) 1999-07-15
JP2002500200A (en) 2002-01-08
PL341604A1 (en) 2001-04-23
NO20003344D0 (en) 2000-06-27
SK284246B6 (en) 2004-12-01
CZ287497B6 (en) 2000-12-13
NO20003344L (en) 2000-06-27

Similar Documents

Publication Publication Date Title
AU3613695A (en) Liposomal agents
AU6319698A (en) Liposomes containing active agents
AU7177798A (en) Cosmetic preparations
IL131259A0 (en) Topical drug preparations
AU1481399A (en) Topical ophthalmic preparations containing immunosuppressive agents
AU1180300A (en) Liquid ophthalmic preparations
AU6729198A (en) Cosmetic preparations
AU2784397A (en) Contrast agents
AU5387898A (en) Pharmaceutical agents
AU4325897A (en) Antifungal agents
AU7177698A (en) Cosmetic preparations
EP0920869A4 (en) Stable aspirin-containing preparations for external use
AU3089199A (en) Preparations containing licariin
AU4059197A (en) Amino-lipopeptide antifungal agents
AU3168597A (en) Dye preparations
AU2025395A (en) Sustained release preparations
AU2650697A (en) Ophthalmic preparations
AU6337294A (en) Ophthalmic topical agent
AU1233399A (en) Colorant preparations
AU3554995A (en) Antipicornaviral agents
AU6473496A (en) Retention agent
AU8243798A (en) Agm-derived stroma cells
AU5998696A (en) Fungicidal active agent combinations
AU4219096A (en) Anti-parasitic activity
AU5002196A (en) Immunosuppressive agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase